AI MARKET SCANNING

$LYTIX.OL

🔒 Europe

LYTIX BIOPHARMA ASA

📅 Next Catalyst: Nov 11, 2026 (☀️ Open) 🏛️ EURONEXT OSLO 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.50%
MAX GAP RECORD +0.50%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $LYTIX.OL
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 11, 2026 Earnings Release 2026-11-11 (BEFORE OPEN) 🔮 UPCOMING 🔒
Aug 27, 2026 Earnings Release 2026-08-27 (AFTER CLOSE)
+0.50%

VOLATILITY & GAP BIAS

AVG GAP MOVE 0.5%
Bullish Gaps (0)
Bearish Gaps (0)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $LYTIX.OL

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Lytix Biopharma ASA engages in the development of novel drugs for the treatment of resistant bacterial and fungal infections, as well as oncology treatments. The company was founded by Øystein Rekdal and John Sigurd Mjøen Svendsen in 2003 and is headquartered in Tromso, Norway.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗